A previous study has shown that inhibition of ALDH activity via all-trans-retinoic acid (ATRA) or specific ALDH inhibitor diethylaminobenzaldehyde (DEAB) in MDA sensitized the initially chemo- and radio-resistant ALDH+ breast cancer cells to the applied treatment [42]. This evidence concerns the gene LDHA and breast cancer.